Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antman, K. H.
Right arrow Articles by Horowitz, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antman, K. H.
Right arrow Articles by Horowitz, M. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal of Clinical Oncology, Vol 15, 1870-1879, Copyright © 1997 by American Society of Clinical Oncology

ARTICLES

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

KH Antman, PA Rowlings, WP Vaughan, CJ Pelz, JW Fay, KK Fields, CO Freytes, RP Gale, BE Hillner, HK Holland, MJ Kennedy, JP Klein, HM Lazarus, PL McCarthy Jr, R Saez, G Spitzer, EA Stadtmauer, SF Williams, S Wolff, KA Sobocinski, JO Armitage and MM Horowitz
Breast Cancer Working Committee of the Autologous Blood and Marrow Transplant Registry of North America, Health Policy Institute, Medical College of Wisconsin, Milwaukee, USA. KHA4@columbia.edu

PURPOSE: To identify trends in high-dose therapy with autologous hematopoietic stem-cell support (autotransplants) for breast cancer (1989 to 1995). PATIENTS AND METHODS: Analysis of patients who received autotransplants and were reported to the Autologous Blood and Marrow Transplant Registry. Between January 1, 1989 and June 30, 1995, 19,291 autotransplants were reviewed; 5,886 were for breast cancer. Main outcomes were progression-free survival (PFS) and survival. RESULTS: Between 1989 and 1995, autotransplants for breast cancer increased sixfold. After 1992, breast cancer was the most common indication for autotransplant. Significant trends included increasing use for locally advanced rather than metastatic disease (P < .00001) and use of blood- derived rather than marrow-derived stem cells (P < .00001). One-hundred- day mortality decreased from 22% to 5% (P < .0001). Three-year PFS probabilities were 65% (95% confidence intervals [Cls], 59 to 71) for stage 2 disease, and 60% (95% Cl, 53 to 67) for stage 3 disease. In metastatic breast cancer, 3-year probabilities of PFS were 7% (95% Cl, 4 to 10) for women with no response to conventional dose chemotherapy; 13% (95% Cl, 9 to 17) for those with partial response; and 32% (95% Cl, 27 to 37) for those with complete response. Eleven percent of women with stage 2/3 disease and less than 1% of those with stage 4 disease participated in national cooperative group randomized trials. CONCLUSION: Autotransplants increasingly are used to treat breast cancer. One-hundred-day mortality has decreased substantially. Three- year survival is better in women with earlier stage disease and in those who respond to pretransplant chemotherapy.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
S. H. Shirley, J. E. Rundhaug, J. Tian, N. Cullinan-Ammann, I. Lambertz, C. J. Conti, and R. Fuchs-Young
Transcriptional Regulation of Estrogen Receptor-{alpha} by p53 in Human Breast Cancer Cells
Cancer Res., April 15, 2009; 69(8): 3405 - 3414.
[Abstract] [Full Text] [PDF]

Home page
 Am Soc Clin Oncol Ed BookHome page
J. Peppercorn
Off-protocol Therapy in Oncology
ASCO Educational Book, January 1, 2009; 2009(1): 177 - 181.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Peppercorn, H. Burstein, F. G. Miller, E. Winer, and S. Joffe
Self-Reported Practices and Attitudes of US Oncologists Regarding Off-Protocol Therapy
J. Clin. Oncol., December 20, 2008; 26(36): 5994 - 6000.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Crump, S. Gluck, D. Tu, D. Stewart, M. Levine, P. Kirkbride, J. Dancey, S. O'Reilly, T. Shore, S. Couban, et al.
Randomized Trial of High-Dose Chemotherapy With Autologous Peripheral-Blood Stem-Cell Support Compared With Standard-Dose Chemotherapy in Women With Metastatic Breast Cancer: NCIC MA.16
J. Clin. Oncol., January 1, 2008; 26(1): 37 - 43.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
H. C.F. Moore, S. J. Green, J. R. Gralow, S. I. Bearman, D. Lew, W. E. Barlow, C. Hudis, A. C. Wolff, J. N. Ingle, H. K. Chew, et al.
Intensive Dose-Dense Compared With High-Dose Adjuvant Chemotherapy for High-Risk Operable Breast Cancer: Southwest Oncology Group/Intergroup Study 9623
J. Clin. Oncol., May 1, 2007; 25(13): 1677 - 1682.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. U. Buzdar
Adjuvant Chemotherapy for High-Risk Operable Breast Cancer
J. Clin. Oncol., May 1, 2007; 25(13): 1642 - 1644.
[Full Text] [PDF]

Home page
 Ann OncolHome page
D. A. Stewart, A. H. G. Paterson, J. D. Ruether, J. Russell, P. Craighead, M. Smylie, and J. Mackey
High-dose mitoxantrone-vinblastine-cyclophosphamide and autologous stem cell transplantation for stage III breast cancer: final results of a prospective multicentre study
Ann. Onc., September 1, 2005; 16(9): 1463 - 1468.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. Somlo, P. Frankel, W. Chow, L. Leong, K. Margolin, R. Morgan Jr, S. Shibata, P. Chu, S. Forman, D. Lim, et al.
Prognostic Indicators and Survival in Patients With Stage IIIB Inflammatory Breast Carcinoma After Dose-Intense Chemotherapy
J. Clin. Oncol., May 15, 2004; 22(10): 1839 - 1848.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. S. Tallman, R. Gray, N. J. Robert, C. F. LeMaistre, C. K. Osborne, W. P. Vaughan, W. J. Gradishar, T. M. Pisansky, J. Fetting, E. Paietta, et al.
Conventional Adjuvant Chemotherapy with or without High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in High-Risk Breast Cancer
N. Engl. J. Med., July 3, 2003; 349(1): 17 - 26.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
A. Schneeweiss, M. Hensel, P. Sinn, T. Khbeis, R. Haas, G. Bastert, and A. D. Ho
Characteristics associated with long-term progression-free survival following high-dose chemotherapy in metastatic breast cancer and influence of chemotherapy dose
Ann. Onc., May 1, 2002; 13(5): 679 - 688.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
D. Cardinale, M. T. Sandri, A. Martinoni, E. Borghini, M. Civelli, G. Lamantia, S. Cinieri, G. Martinelli, C. Fiorentini, and C. M. Cipolla
Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy
Ann. Onc., May 1, 2002; 13(5): 710 - 715.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. A. Berry, G. Broadwater, J. P. Klein, K. Antman, J. Aisner, J. Bitran, M. Costanza, C. O. Freytes, E. Stadtmauer, R. P. Gale, et al.
High-Dose Versus Standard Chemotherapy in Metastatic Breast Cancer: Comparison of Cancer and Leukemia Group B Trials With Data From the Autologous Blood and Marrow Transplant Registry
J. Clin. Oncol., February 1, 2002; 20(3): 743 - 750.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Sato, Y. Torimoto, Y. Tamura, M. Shindo, H. Shinzaki, K. Hirai, and Y. Kohgo
Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice
Blood, September 15, 2001; 98(6): 1852 - 1857.
[Abstract] [Full Text] [PDF]

Home page
 Health Aff (Millwood)Home page
M. M. Mello and T. A. Brennan
The Controversy Over High-Dose Chemotherapy With Autologous Bone Marrow Transplant For Breast Cancer
Health Aff., September 1, 2001; 20(5): 101 - 117.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. B. Weiss, G. G. Gill, and C. A. Hudis
An On-Site Audit of the South African Trial of High-Dose Chemotherapy for Metastatic Breast Cancer and Associated Publications
J. Clin. Oncol., June 1, 2001; 999(1): 1 - 8.
[Abstract] [Full Text]

Home page
 JCOHome page
R. B. Weiss, G. G. Gill, and C. A. Hudis
An On-Site Audit of the South African Trial of High-Dose Chemotherapy for Metastatic Breast Cancer and Associated Publications
J. Clin. Oncol., June 1, 2001; 19(11): 2771 - 2777.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. Strother, D. Ashley, S. J. Kellie, A. Patel, D. Jones-Wallace, S. Thompson, R. Heideman, E. Benaim, R. Krance, L. Bowman, et al.
Feasibility of Four Consecutive High-Dose Chemotherapy Cycles With Stem-Cell Rescue for Patients With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor After Craniospinal Radiotherapy: Results of a Collaborative Study
J. Clin. Oncol., May 15, 2001; 19(10): 2696 - 2704.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Wu, A. Mazumder, R. L. Martuza, X. Liu, M. Thein, K. R. Meehan, and S. D. Rabkin
Biological Purging of Breast Cancer Cells Using an Attenuated Replication-competent Herpes Simplex Virus in Human Hematopoietic Stem Cell Transplantation
Cancer Res., April 1, 2001; 61(7): 3009 - 3015.
[Abstract] [Full Text]

Home page
 BMJHome page
L. Allan, L. Tooke, J. N Rao, P. Bruzzi, M. Costantini, I. Szebik, S. Bydder, T. Slevin, and P. Katris
Giving medicine a fair trial
BMJ, December 16, 2000; 321(7275): 1529a - 1529.
[Full Text]

Home page
 The OncologistHome page
S. Rodenhuis
The Status of High-Dose Chemotherapy in Breast Cancer
Oncologist, October 1, 2000; 5(5): 369 - 375.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
P. Pedrazzoli, A. S. Bianchi, M. Renga, and S. Siena
Re: Randomized Trial of High-Dose Chemotherapy and Blood Cell Autografts for High-Risk Primary Breast Carcinoma
J Natl Cancer Inst, August 2, 2000; 92(15): 1271 - 1272.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
G. N. Hortobagyi and A. U. Buzdar
RESPONSE: Re: Randomized Trial of High-Dose Chemotherapy and Blood Cell Autografts for High-Risk Primary Breast Carcinoma
J Natl Cancer Inst, August 2, 2000; 92(15): 1273 - 1273.
[Full Text] [PDF]

Home page
 JCOHome page
A. Patnaik, J. MacKinnon, P. Goss, T. Nagy, K. Stewart, A. Keating, and M. Crump
Phase I/II Trial of Cyclophosphamide, Mitoxantrone, and Escalated Doses of Carboplatin Supported by Peripheral-Blood Stem Cells in Women With Metastatic Breast Cancer
J. Clin. Oncol., June 12, 2000; 18(12): 2363 - 2368.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Gilewski, S. Adluri, G. Ragupathi, S. Zhang, T.-J. Yao, K. Panageas, M. Moynahan, A. Houghton, L. Norton, and P. O. Livingston
Vaccination of High-Risk Breast Cancer Patients with Mucin-1 (MUC1) Keyhole Limpet Hemocyanin Conjugate plus QS-21
Clin. Cancer Res., May 1, 2000; 6(5): 1693 - 1701.
[Abstract] [Full Text]

Home page
 NEJMHome page
E. A. Stadtmauer, A. O'Neill, L. J. Goldstein, P. A. Crilley, K. F. Mangan, J. N. Ingle, I. Brodsky, S. Martino, H. M. Lazarus, J. K. Erban, et al.
Conventional-Dose Chemotherapy Compared with High-Dose Chemotherapy plus Autologous Hematopoietic Stem-Cell Transplantation for Metastatic Breast Cancer
N. Engl. J. Med., April 13, 2000; 342(15): 1069 - 1076.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
G. N. Hortobagyi, A. U. Buzdar, R. L. Theriault, V. Valero, D. Frye, D. J. Booser, F. A. Holmes, S. Giralt, I. Khouri, B. Andersson, et al.
Randomized Trial of High-Dose Chemotherapy and Blood Cell Autografts for High-Risk Primary Breast Carcinoma
J Natl Cancer Inst, February 2, 2000; 92(3): 225 - 233.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
W. P. Peters, R. D. Dansey, J. L. Klein, and R. D. Baynes
High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Transplantation in the Treatment of Breast Cancer
Oncologist, February 1, 2000; 5(1): 1 - 13.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. S. BHALLA, S. W. WILCZYNSKI, A. M. ABUSHAMAA, W. P. PETROS, C. S. MCDONALD, J. S. LOFTIS, N. J. CHAO, J. J. VREDENBURGH, and R. J. FOLZ
Pulmonary Toxicity of Induction Chemotherapy Prior to Standard or High-dose Chemotherapy with Autologous Hematopoietic Support
Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 17 - 25.
[Abstract] [Full Text]

Home page
 BloodHome page
L. A. Holmberg, M. Boeckh, H. Hooper, W. Leisenring, S. Rowley, S. Heimfeld, O. Press, D. G. Maloney, P. McSweeney, L. Corey, et al.
Increased Incidence of Cytomegalovirus Disease After Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation
Blood, December 15, 1999; 94(12): 4029 - 4035.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
R. B. Weiss
The Randomized Trials of Dose-Intensive Therapy for Breast Cancer: What Do They Mean for Patient Care and Where Do We Go From Here?
Oncologist, December 1, 1999; 4(6): 450 - 458.
[Abstract] [Full Text]

Home page
 JAMAHome page
K. H. Antman, D. F. Heitjan, and G. N. Hortobagyi
High-Dose Chemotherapy for Breast Cancer
JAMA, November 10, 1999; 282(18): 1701 - 1703.
[Full Text] [PDF]

Home page
 JCOHome page
R. Livingston and J. Crowley
Commentary on PBT-1 Study of High-Dose Consolidation Versus Standard Therapy in Metastatic Breast Cancer
J. Clin. Oncol., November 1, 1999; 17(90001): 22 - 24.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W. W. Hu, G. D. Long, K. E. Stockerl-Goldstein, L. J. Johnston, N. J. Chao, R. S. Negrin, and K. G. Blume
A Feasibility Study of Multiple Cycle Therapy with Melphalan, Thiotepa, and Paclitaxel followed by Mitoxantrone, Thiotepa, and Paclitaxel with Autologous Hematopoietic Cell Support for Metastatic Breast Cancer
Clin. Cancer Res., November 1, 1999; 5(11): 3411 - 3418.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
P. A. Rowlings, S. F. Williams, K. H. Antman, K. K. Fields, J. W. Fay, E. Reed, C. J. Pelz, J. P. Klein, K. A. Sobocinski, M. J. Kennedy, et al.
Factors Correlated With Progression-Free Survival After High-Dose Chemotherapy and Hematopoietic Stem Cell Transplantation for Metastatic Breast Cancer
JAMA, October 13, 1999; 282(14): 1335 - 1343.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
W. J. Gradishar
High-Dose Chemotherapy and Breast Cancer
JAMA, October 13, 1999; 282(14): 1378 - 1380.
[Full Text] [PDF]

Home page
 JCOHome page
D. A. Rizzieri, J. J. Vredenburgh, R. Jones, M. Ross, E. J. Shpall, A. Hussein, G. Broadwater, D. Berry, W. P. Petros, C. Gilbert, et al.
Prognostic and Predictive Factors for Patients With Metastatic Breast Cancer Undergoing Aggressive Induction Therapy Followed by High-Dose Chemotherapy With Autologous Stem-Cell Support
J. Clin. Oncol., October 1, 1999; 17(10): 3064 - 3074.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. J. O'HEARN, K. M. LEIFERMAN, F. ASKIN, and S. N. GEORAS
Pulmonary Infiltrates after Cytokine Therapy for Stem Cell Transplantation . Massive Deposition of Eosinophil Major Basic Protein Detected by Immunohistochemistry
Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1361 - 1365.
[Abstract] [Full Text]

Home page
 JCOHome page
H. Schirrmeister, A. Guhlmann, J. Kotzerke, C. Santjohanser, T. Kuhn, R. Kreienberg, P. Messer, K. Nussle, K. Elsner, G. Glatting, et al.
Early Detection and Accurate Description of Extent of Metastatic Bone Disease in Breast Cancer With Fluoride Ion and Positron Emission Tomography
J. Clin. Oncol., August 1, 1999; 17(8): 2381 - 2381.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. Adkins, R. Brown, K. Trinkaus, R. Maziarz, S. Luedke, C. Freytes, B. Needles, D. Wienski, P. Fracasso, T. Pluard, et al.
Outcomes of High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in Stage IIIB Inflammatory Breast Cancer
J. Clin. Oncol., July 1, 1999; 17(7): 2006 - 2006.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. H. Cowan, J. A. Moscow, H. Huang, J. A. Zujewski, J. O'Shaughnessy, B. Sorrentino, K. Hines, C. Carter, E. Schneider, G. Cusack, et al.
Paclitaxel Chemotherapy after Autologous Stem-Cell Transplantation and Engraftment of Hematopoietic Cells Transduced with a Retrovirus Containing the Multidrug Resistance Complementary DNA (MDR1) in Metastatic Breast Cancer Patients
Clin. Cancer Res., July 1, 1999; 5(7): 1619 - 1628.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Mohr, E. Hilgenfeld, T. Fietz, B. Hoppe, M. Koenigsmann, M. Hoffmann, W. U. Knauf, U. Cassens, W. Sibrowski, J. Kienast, et al.
Efficacy and Safety of Simultaneous Immunomagnetic CD34+ Cell Selection and Breast Cancer Cell Purging in Peripheral Blood Progenitor Cell Samples Used for Hematopoietic Rescue after High-Dose Therapy
Clin. Cancer Res., May 1, 1999; 5(5): 1035 - 1040.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
C. L. Vogel and J.-M. Nabholtz
Monotherapy of Metastatic Breast Cancer: A Review of Newer Agents
Oncologist, February 1, 1999; 4(1): 17 - 33.
[Abstract] [Full Text]

Home page
 BloodHome page
A. Spyridonidis, W. Bernhardt, D. Behringer, G. Kohler, M. Azemar, A. Pflug, and R. Henschler
Proliferation and Survival of Mammary Carcinoma Cells Are Influenced by Culture Conditions Used for Ex Vivo Expansion of CD34+ Blood Progenitor Cells
Blood, January 15, 1999; 93(2): 746 - 755.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
G. N. Hortobagyi
Treatment of Breast Cancer
N. Engl. J. Med., October 1, 1998; 339(14): 974 - 984.
[Full Text] [PDF]

Home page
 The OncologistHome page
S. Subramanyan and M. J. Kennedy
Breast Cancer: High-Dose Therapy
Oncologist, October 1, 1998; 3(5): 289 - 299.
[Abstract] [Full Text]

Home page
 The OncologistHome page
C.H. Weaver, W. West, L. Schwartzberg, R. Birch, and C.D. Buckner
The Rationale for Performing Autologous Peripheral Blood Stem Cell Transplants in Community Cancer Centers
Oncologist, October 1, 1998; 3(5): 346 - 353.
[Abstract] [Full Text]

Home page
 JWatch GeneralHome page
HIGH-DOSE CHEMOTHERAPY PLUS AUTOTRANSPLANTATION FOR BREAST CANCER
Journal Watch (General), May 30, 1997; 1997(530): 3 - 3.
[Full Text]


About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 1997 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online